Ibrahim, A., Ghaleb, R., Mansour, H., Hanafy, A., Mahmoud, N. M., Abdelfatah Elsharef, M., . . . Abdel-Galeel, A. (2020). Safety and Efficacy of Adding Dapagliflozin to Furosemide in Type 2 Diabetic Patients With Decompensated Heart Failure and Reduced Ejection Fraction. Front Cardiovasc Med.
Stile di citazione ChicagoIbrahim, Ayman, et al. "Safety and Efficacy of Adding Dapagliflozin to Furosemide in Type 2 Diabetic Patients With Decompensated Heart Failure and Reduced Ejection Fraction." Front Cardiovasc Med 2020.
Citazione MLAIbrahim, Ayman, et al. "Safety and Efficacy of Adding Dapagliflozin to Furosemide in Type 2 Diabetic Patients With Decompensated Heart Failure and Reduced Ejection Fraction." Front Cardiovasc Med 2020.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.